CIK 0001790340
- Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $89,500
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$89,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-03 | Barrett Scott Chief Medical Officer | Conversion · Series B Preferred Stock | −2,723 | 0 | ||
| 2021-08-03 | Amin Biren CFO, Treasurer | Conversion | +2,723 | 2,723 | ||
| 2021-08-03 | Amin Biren CFO, Treasurer | Purchase | +4,175 | $15.00 | $63K | 6,898 |
| 2021-08-03 | Amin Biren CFO, Treasurer | Conversion · Series B Preferred Stock | −2,723 | 0 | ||
| 2021-07-29 | Bookman Michael General Counsel and Secretary | Grant or award · Stock Option | −101,116 | 101,116 | ||
| 2021-07-29 | BERMAN ANN E Director | Grant or award · Stock Option | −28,371 | 28,371 |
Page 12 of 12 · 226 trades